SEC Form 4 · accession 0001017491-17-000014
SEELOS THERAPEUTICS, INC. · SEEL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Paul V Maier
Director
Period of report
Jan 5, 2017
Accepted (ET)
Jan 6, 2017 · 7:30 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001017491
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Jan 5, 2017 | A | 11,250 | — | A | 13,854 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The Restricted Stock Units ("RSUs") were issued to the Reporting Person, a non-employee director of the Issuer, as an annual equity grant for his service as a director of the Issuer. Such RSUs shall fully vest on the first anniversary of the grant date, January 5, 2018, and are subject to accelerated vesting upon a change of control of the Issuer.
- F2Not applicable.